PT - JOURNAL ARTICLE AU - Maanja, Maren AU - Schlegel, Todd T AU - Kozor, Rebecca AU - Bacharova, Ljuba AU - Wong, Timothy C. AU - Schelbert, Erik B AU - Ugander, Martin TI - Improved evaluation of left ventricular hypertrophy using the spatial QRS-T angle by electrocardiography AID - 10.1101/2022.01.10.22268661 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.10.22268661 4099 - http://medrxiv.org/content/early/2022/01/10/2022.01.10.22268661.short 4100 - http://medrxiv.org/content/early/2022/01/10/2022.01.10.22268661.full AB - Background Conventional electrocardiographic (ECG) signs of left ventricular hypertrophy (LVH) lack sensitivity. The aim was to identify LVH based on an abnormal spatial peaks QRS-T angle, and evaluate its diagnostic and prognostic performance compared to that of conventional ECG criteria for LVH.Methods This was an observational study with four cohorts, all with a QRS duration <120 ms: (1) Healthy volunteers to define normality (n=921), (2) Separate healthy volunteers to compare test specificity (n=461), (3) Patients with at least moderate LVH by cardiac imaging (Imaging-LVH) to compare test sensitivity (n=225), and (4) Patients referred for cardiovascular magnetic resonance imaging to evaluate the combined outcome of hospitalization for heart failure or all-cause death (Clinical-Consecutive, n=783).Results An abnormal spatial peaks QRS-T angle was defined as exceeding the upper limit of normal, which was found to be ≥ 40° for females and ≥ 55° for males. In healthy volunteers, the specificity of the QRS-T angle to detect LVH was 96% (females) and 98% (males). In Imaging-LVH, the QRS-T angle had a higher sensitivity to detect LVH than conventional ECG criteria (93–97% vs 13–56%, p<0.001 for all). In Clinical-Consecutive, of those who did not have any LVH, 238/556 (43%) had an abnormal QRS-T angle, suggesting it can occur even without LVH. There was an association with outcomes in univariable analysis for the QRS-T angle, Cornell voltage, QRS duration, and Cornell product (hazard ratios 1.68–2.5, p<0.01 for all) that persisted in multivariable analysis only for the QRS-T angle and QRS duration (p<0.001 for both).Conclusions An increased QRS-T angle rarely occurred in healthy volunteers, was a mainstay of moderate or greater LVH, was common in clinical patients without LVH but with cardiac co-morbidities, and associated with outcomes. Thus, an increased QRS-T angle identifies left ventricular electrical remodeling that can occur in the absence of LVH detected by imaging. The improved diagnostic and independent prognostic performance for the QRS-T angle suggests that it should be investigated when ECGs are evaluated.Competing Interest StatementDr. Schlegel is a principal of Nicollier-Schlegel SARL, a company that performs ECG research consultancy using the software used in the present study. Dr. Ugander reports non-financial support from Siemens Healthcare outside the submitted work.Funding StatementThis work was supported in part by grants from the Swedish Research Council, Swedish Heart and Lung Foundation, Stockholm County Council, and Karolinska Institutet.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the University of Pittsburgh Medical Center Institutional Review Board. The study was approved by the NASA Johnsons Space Center Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be made available upon reasonable request.